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Introduction {#sec1}
============

Human pluripotent stem cells (hiPSCs) offer an attractive tool for modeling brain development and disease based on their ability to be directed and differentiated into human cerebral organoids and cells ([@bib16]). Generated from hiPSCs, neural progenitor cells (NPCs) can be used to generate neuronal and glial cells ([@bib21], [@bib29]). Direction of these cells into specific cell types allows for identification of the underlying neuropathology and also presents the possibility of replacement therapy for neurodegenerative diseases such as Parkinson\'s disease (PD), which is caused by selective loss of dopaminergic (DA) neurons in the substantia nigra pars compacta in the midbrain ([@bib15]).

We have recently revealed ([@bib9], [@bib10]) an active and pivotal role for mitochondria in midbrain DA and cortical neurogenesis. Induced defects in mitochondrial respiratory chains via application of a complex IV inhibitor, KCN (potassium cyanide), or complex I inhibitor, rotenone, restricted neurogenesis of DA neurons. Accumulating studies have demonstrated that astrocytes, the most populous glial cells and important coordinative partners to neighboring neuronal cells, are essential in DA neurogenesis in the subventricular zone of the lateral ventricles, a region for neurogenesis in the midbrain of adult brains, and disruption in astrocytic function promotes neurodegeneration ([@bib18]). Here, we induced DA neuron differentiation with mature astrocyte co-culture, to mimic the *in vivo* neuronal-astroglial interaction environment. In the presence of astrocytes, NPCs were resistant to mitochondrial respiratory defects and exhibited normal differentiation into DA neurons. Importantly, using this dynamic astrocyte-neuron interaction model, we clearly display the essential role of mitochondria in DA neuronal differentiation and maturation. Furthermore, astrocytes actively modulate normal neuronal development by rescuing neuronal mitochondrial defects in the process of DA-directed differentiation. This human neuron-glia cross-talk model will facilitate evaluation of the role of astrocytes in modulating mitochondrial function in the pathogenesis of neurodegenerative diseases and identification of therapeutic applications in mitochondrial degeneration.

Results {#sec2}
=======

Efficient Differentiation of GFAP+ Mature Human Astrocytes from NPCs {#sec2.1}
--------------------------------------------------------------------

We have previously shown that human DA neurons are derived from NPCs ([@bib9]). In this study, NPCs derived from BM2-3 hiPSCs were differentiated into astrocytes. Following the protocol shown in [Figure S1](#mmc1){ref-type="supplementary-material"}A, S100β-positive cells were derived from astroglial progenitor cells after about 70 days induction with ciliary neurotrophic factor (CNTF) in astroglial medium ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Emergence of an astrocyte-like phenotype following 70 days induction was indicated by expression of the astrocyte markers S100β and GFAP ([Figure S1](#mmc1){ref-type="supplementary-material"}A).

Populations of GFAP-positive astrocytes were robustly increased between the 3rd and the 9th month of differentiation by removing growth factors epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2) ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Definitive mature astrocytes with expression of GFAP appeared 3 to 9 months following removal of growth factors EGF and FGF2 from astroglial medium ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Astrocyte maturation was characterized by the presence of the astrocyte marker GFAP ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S1](#mmc1){ref-type="supplementary-material"}C). Quantification of GFAP-positive cells showed that the percentage of GFAP-expressing cells was 27.7% and 83.8% with 3 and 9 months of differentiation, respectively (quantification data not shown). In contrast, GFAP expression in human DA neuronal cultures was barely detected compared with astroglial culture ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}D). DA neurons were verified by the absence of TH (tyrosine hydroxylase) expression in 9-month astroglial culture ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S1](#mmc1){ref-type="supplementary-material"}D). Therefore, 9-month mature astrocytes were used in our co-culture system.Figure 1Differentiation and Development of hiPSC Line-Induced Human Dopaminergic Neurons and Astrocytes(A) A schematic representation of the differentiation of mitochondrial inhibitor/toxin (KCN or rotenone)-treated hiPSC line-induced DA neurons with astroglial co-culture. EB, embryoid body.(B) Immunocytochemistry of synaptophysin (Syn)-positive (green) puncta and TH (red) in neural progenitor cells (NPCs; **I**) and mature DA neurons (**II**) and mature astroglial marker (GFAP, green) and astroglial progenitor marker (S100β, red) in NPCs (**III**) and astrocytes induced for 9 months (**IV**).(C) Representative immunoblots for GFAP and TH expression in NPCs, astrocytes induced for 9 months, and DA neurons. β-actin was used as a protein loading control. ^∗∗^p \< 0.01 versus NPCs and DA neurons (open bars, GFAP), and ^\#\#^p \< 0.01 versus NPCs and DA neurons (black bars, TH).Scale bars, 25 μm in (B). For (C), statistical analysis was performed using StatView software (SAS Institute, v.5.0.1). One-way ANOVA was used for repeated-measure analysis, followed by Fisher\'s protected least significant difference for post hoc comparisons. Data are presented as means ± SEM. n = 3 independent experiments.

Co-culture with Astrocytes Rescues Impaired DA Neuronal Differentiation and Synaptogenesis {#sec2.2}
------------------------------------------------------------------------------------------

Accumulating evidence indicates the emerging role of astrocytes in the pathogenesis of neurological disorders, such as PD ([@bib20]). Given the importance of mitochondrial respiratory function in DA neuron differentiation and synaptogenesis ([@bib9]), we investigated the effect of astrocytes on DA neuronal development under respiratory chain impairment using a neuron-astrocyte co-culture system. Impairment of mitochondrial respiratory function was induced by the addition of inhibitor for complex IV (KCN, 500 nM) and complex I (rotenone, 10 nM), as we previously described ([@bib9]). Consistent with our previous results, KCN- or rotenone-induced inhibition of mitochondrial respiratory function significantly suppressed synapse development and maturation of DA neurons. However, with astrocyte co-culture, the lengths of MAP2 (a marker for neuronal dendrites)- and TH (a marker for DA neurons)-positive processes of neurons were significantly longer compared with those neurons without astrocyte co-culture in the presence of KCN or rotenone ([Figures 2](#fig2){ref-type="fig"}A and 2B). The number of synaptophysin-positive puncta in TH dendrites was also significantly increased ([Figures 2](#fig2){ref-type="fig"}A and 2C). Accordingly, quantitative real-time PCR showed that levels of mature DA neuronal markers, including *aromatic L-amino acid decarboxylase* (*AADC*), *dopamine transporter* (*DAT*), and *vesicular monoamine transporter 2* (*VMAT2*), and the marker for mature neurons, *microtubule-associated protein 2* (*MAP2*), were markedly elevated with astroglia co-culture ([Figures 2](#fig2){ref-type="fig"}D--2G). These results indicate that co-culture with astrocytes restores DA neuronal differentiation ability and synaptogenesis by improving mitochondrial function. Given that soma size is an important index for neuronal morphology and development, we further analyzed soma size of DA neurons in the aforementioned treatments. No significant changes in soma size of DA neurons were observed between DA neurons with and without astrocyte co-culture exposed to KCN or rotenone (data not shown).Figure 2Astrocyte Co-culture Rescues Differentiation of hiPSC Line-Induced Human DA Neurons under KCN or Rotenone Treatment(A) Representative images for immunostaining of MAP2 (green), TH (red), and Syn (white, color changed from far red) in induced DA neurons treated with KCN or rotenone with or without astrocyte co-culture. Scale bars, 25 μm.(B) Quantification of neuronal process length of MAP2-positive neurons and TH-positive DA neurons using NIH ImageJ program.(C) Quantification of numbers of Syn-positive clusters along the branches of hiPSC-derived DA neurons (TH-positive dendrites).(D--G) Quantitative real-time PCR results of the indicated gene expression levels of *AADC* (D), *DAT* (E), *VMAT2* (G), and *MAP2* (F) in DA neurons with (+) or without (−) co-culture of astrocytes in the presence of vehicle, KCN, or rotenone.Scale bars, 25 μm in (A). For (B)--(G), ^∗∗^p \< 0.01 versus the vehicle group. Statistical analysis was performed using StatView software (SAS Institute, v.5.0.1). One-way ANOVA was used for repeated-measure analysis, followed by Fisher\'s protected least significant difference for post hoc comparisons. Data are presented as means ± SEM. n = 3 independent experiments, with 12--13 cells quantified per experiment in (B) and (C). n = 3 independent experiments in (D)--(G).

Co-culture with Astrocytes Rescues Mitochondrial Defects in hiPSC-Differentiated DA Neurons {#sec2.3}
-------------------------------------------------------------------------------------------

To further determine the effect of astroglial co-culture on neuronal mitochondrial functions, we evaluated the activity of mitochondrial complexes I and IV (key respiratory chain enzymes), ATP levels, and mitochondrial reactive oxygen species (ROS) levels. Co-culture with astrocytes rescued KCN or rotenone-induced mitochondrial dysfunction as shown by increased complex IV and I activities and ATP levels in DA neurons ([Figures 3](#fig3){ref-type="fig"}A--3C). Furthermore, in the presence of astrocytes, mitochondrial ROS levels evaluated by MitoSOX staining intensity in TH+ neuronal terminals ([Figures 3](#fig3){ref-type="fig"}D and 3E) and intracellular ROS levels measured by highly specific electron paramagnetic resonance (EPR) spectroscopy ([Figures 3](#fig3){ref-type="fig"}F and 3G) were both significantly diminished in DA neurons exposed to KCN or rotenone. These results demonstrate that astroglial co-culture rescues mitochondrial respiratory function defects and eliminates ROS overproduction and accumulation during differentiation of hiPSCs into DA neurons.Figure 3Effect of Astrocyte Co-culture on Mitochondrial Functions in hiPSC Line-Induced Human DA Neurons under KCN or Rotenone Treatment(A--C) Complex IV (A) and I (B) activity and ATP levels (C) were determined in hiPSC-derived DA neurons treated with KCN or rotenone with or without astrocyte co-culture. Data are expressed as fold change relative to the vehicle group in (A)--(C) (n = 3 independent experiments; mean ± SEM).(D and E) Mitochondrial ROS levels were measured by MitoSOX staining. Representative images for MitoSOX staining for hiPSC-derived DA neurons with the above treatments are shown in (D), and quantification of MitoSOX staining intensity is shown in (E) (n = 3 independent experiments; mean ± SEM, with five cells quantified per experiment). Scale bars, 10 μm in (D).(F and G) Assessment of intracellular ROS levels measured by EPR spectroscopy. Representative images for EPR are shown in (F), and quantifications are shown in (G) (n = 3 independent experiments; mean ± SEM).^∗^p \< 0.05 versus the vehicle group (C, E, and G). Statistical analysis was performed using Statview software (SAS Institute, Version 5.0.1). One-way ANOVA was used for repeated measure analysis, followed by Fisher's protected least significant difference for post hoc comparisons (A--C, E, and G).

Co-culture with Astrocytes Protects against Mitochondria Toxin-Induced Alterations in Mitochondrial Morphology and Mobility in hiPSC-Differentiated DA Neurons {#sec2.4}
--------------------------------------------------------------------------------------------------------------------------------------------------------------

Finally, we investigated mitochondrial morphology and mobility in the processes of hiPSC-differentiated DA neurons. Cumulative distribution data in [Figure 4](#fig4){ref-type="fig"}A clearly demonstrate that astroglial co-culture increases the percentage of long mitochondria in hiPSC-differentiated DA neurons under KCN or rotenone treatment. Mitochondrial travel distance and velocity were significantly increased in DA neurons co-cultured with astrocytes compared with DA neurons without astrocytes in the presence of KCN or rotenone ([Figures 4](#fig4){ref-type="fig"}B and 4C). Similarly, the percentages of anterograde, retrograde, and movable mitochondria were all increased ([Figures 4](#fig4){ref-type="fig"}D and 4E), whereas the percentage of stationary mitochondria was decreased in neurons cultured with astrocytes ([Figure 4](#fig4){ref-type="fig"}D). Representative kymograph images revealed more movable mitochondria in the neuronal processes of KCN- and rotenone-treated DA neurons with astroglial co-culture ([Figure 4](#fig4){ref-type="fig"}F). Video recorded from living mitochondrial images revealed a significant improvement in mitochondrial movement speed and travel distance with astrocyte co-culture ([Movie S1](#mmc2){ref-type="supplementary-material"}). Collectively, our results indicate that astrocytes reverse mitochondrial morphological and dynamic defects in hiPSC-derived DA neurons insulted by mitochondrial toxins.Figure 4Effect of Astrocyte Co-culture on Mitochondrial Dynamic Parameters in hiPSC-Derived DA Neurons under KCN or Rotenone Treatment(A) Cumulative distribution data showed increases in the numbers of long mitochondria in hiPSC-derived DA neurons treated with KCN or rotenone with or without astrocyte co-culture.(B and C) Average mitochondrial travel distance (B) and mitochondrial travel velocity (C) were calculated. Longer mitochondrial travel distance and higher mitochondrial travel velocity were obtained from DA neurons with astrocyte co-culture. ^∗∗^p \< 0.01 versus the vehicle group.(D and E) Higher percentage of movable and lower percentage of stationary (D) and more anterograde and retrograde movable mitochondria (E) in DA neurons with astrocyte co-culture. n = 3 independent experiments; mean ± SEM, with 10 mitochondrial movements quantified per experiment in (B)--(E). ^∗∗^p \< 0.01 versus the open and gray bars in the KCN- and rotenone-treated groups without astrocyte (−), respectively. ^\#^p \< 0.05 and ^\#\#^p \< 0.01 versus the open and gray bars in the KCN-treated groups (−), respectively. ^▵^p \< 0.05 and ^▵▵^p \< 0.01 versus the open and gray bars in the rotenone-treated groups (−), respectively. Statistical analysis was performed using Statview software (SAS Institute, Version 5.0.1). One-way ANOVA was used for repeated measure analysis, followed by Fisher's protected least significant difference for post hoc comparisons (B--E).(F) Kymographs generated from live-imaging movies represent hiPSC-derived DA neurons cultured with above treatments. In the kymographs, the x axis is mitochondrial position and the y axis represents the time lapse of 0--120 s. Vertical white lines represent stationary mitochondria and diagonal lines represent moving mitochondria. Anterograde movements are from left to right and retrograde movements are from right to left. Scale bar, 10 μm.

Discussion {#sec3}
==========

Accumulating evidence now suggests that astrocytes are key neuromodulators that actively communicate/cross talk with neurons during different phases of neurodevelopment ([@bib14], [@bib29]). Astroglial cells are involved in many cellular functions, including providing trophic support for neurons, neurotransmission, metabolite and electrolyte homeostasis, cell signaling, inflammation, and synapse modulation in the CNS ([@bib24]). Loss of normal homeostatic function, toxic stimulation, or a combination of both activates astrocytes, contributing to the neuropathology of neurodegenerative diseases ([@bib1], [@bib4]).

Recently, several studies have demonstrated that astrocytes generated from hiPSCs mimic normal development and functions *in vivo* ([@bib26], [@bib27]). Exposure to FGF was sufficient to induce a mature quiescent spinal cord astrocyte phenotype ([@bib25]). CNTF has been shown to direct differentiation of precursor cells into astrocytes while inhibiting neuronal differentiation ([@bib3]). By application of FGF at the astroglial progenitor stage and CNTF at the late stage, we directed hiPSCs into mature GFAP-positive astrocytes 9 months after astroglial induction.

In the CNS, astrocytes have been widely shown to protect neurons from oxidative insults ([@bib28], [@bib29]). The co-culture system offers a model for mimicking the *in vivo* environment for detailed study of the astrocyte-neuron coordination relationship. In this study, using transwell inserts plated with mature astrocytes, mitochondrial development and differential ability were restored in DA neurons with mitochondrial respiratory inhibitor insult. Similarly, incubation of astrocyte conditioned medium protects against mitochondrial toxin-induced defects in mitochondrial function, differentiation, and synaptogenesis in hiPSC line-induced human DA neurons ([Figure S2](#mmc1){ref-type="supplementary-material"}). These findings indicate that astrocytes are of key importance in modulating neuronal mitochondrial dysfunction induced by mitochondrial insults *in vivo*.

Mitochondria, highly dynamic organelles and the primary energy-generating system, contain complex structures involved in multiple processes, including energy metabolism, ROS generation, and mitochondrial dynamics and distribution. Mitochondrial defects occur in a wide variety of degenerative diseases such as aging, mal-neurodevelopment, and neurodegenerative diseases ([@bib22]). Excess mitochondrial ROS in NPCs could lead to mitochondrial dysfunctions, resulting in failure of DA neurons to differentiate ([@bib9]). Since astrocytes are potent scavengers of ROS, neurons are damaged by oxidative stress triggered by the impaired redox scavenging ability of dysfunctional astrocytes ([@bib7]). Indeed, astroglial-neuronal co-culture reduced intracellular mitochondrial ROS levels and restored mitochondrial function along with differentiation of DA neurons insulted by mitochondrial toxin, suggesting the protective effect of astrocytes on DA neuronal function and differentiation is, at least in part, via suppressing ROS to stabilize mitochondrial functions.

Mitochondrial ROS is a strong stimulus, which activates many signal pathways and transcription factors, including nuclear factor κB and p38 or ERK mitogen-activated protein (MAP) kinases. Oxidative stress-mediated activation of p38 MAP kinase contributes to aberrant axonal mitochondrial transport and aberrant mitochondrial dynamics and function ([@bib34], [@bib33]). Disruption of ERK MAP kinase signaling perturbs the balance of mitochondrial dynamics via increased mitochondrial fission protein Dlp1 expression in Alzheimer\'s disease trans-mitochondrial "cybrid" (cytoplasmic hybrid) neuronal cells ([@bib11], [@bib12]). Our most recent study demonstrated the link of mitochondrial ROS to mitochondrial clearance through the PINK1-mediated autophagy pathway to maintain homeostasis of mitochondria ([@bib8]). Thus, mitochondrial ROS-initiated signals may contribute importantly to the astrocyte-involved DA neuronal maturation and synaptogenesis.

Mitochondria continuously undergo fission and fusion cycles. During DA neuronal differentiation, mitochondria favor the fusion process ([@bib9]). The fission and fusion balance is maintained via quality control of mitochondrial proteins, such as Drp1, a key mitochondrial fission protein found to be indispensable in somatic cell reprogramming to pluripotency ([@bib30]), and fusion proteins. Importantly, mitochondrial trafficking regulator Miro1 (Mitochondrial Rho GTPase 1), a key factor in normal embryonic development, is also involved in the differentiation of iPSCs ([@bib5], [@bib31]).

In addition, multiple trophic factors as bFGF, BDNF, GDNF, and NGF, derived from astrocytes, have been implicated in regulating mesencephalic DA neuronal survival, differentiation, and synaptic plasticity *in vitro* and *in vivo* ([@bib17], [@bib32]). These tropic factors are potentially important for the astrocyte-involved mitochondrial improvement, synaptogenesis, and development of DA.

Endoplasmic reticulum (ER) stress results in accumulation of unfolded or misfolded proteins in the ER lumen. ER and mitochondria form networks essential to maintain cellular homeostasis; therefore, ER stress perturbs mitochondrial function ([@bib19]). Under chronic KCN and rotenone treatments, the protein disulfide isomerase, a stress protein abundant in ER, and the ER chaperone glucose-regulated protein 78 were elevated in the DA neurons ([Figure S3](#mmc1){ref-type="supplementary-material"}). Notably, co-culture with astrocytes almost abolished KCN- or rotenone-mediated upregulation of these ER stress markers. These results suggest a possible link of mitochondrial dysfunction to ER stress via astrocytes, contributing to the normal differentiation and synaptogenesis in DA neurons.

Mitochondrial dysfunction and oxidative stress play a major role in the pathogenesis of PD. Deficiency of mitochondrial complex I of the respiratory chain has long been implicated in the cause of the degeneration of PD-affected neurons ([@bib23]). In addition, combined decreased complex I and IV activity was seen in the platelet mitochondria of PD ([@bib2]) and 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine (MPTP)- or 6-hydroxydopamine-induced animal models of PD ([@bib6], [@bib13]). Here, we induced DA neuron differentiation by co-culture with mature astrocytes to mimic the *in vivo* neuronal-astroglial interaction environment. Therefore, evaluation of the consequences of mitochondrial toxin-mediated inhibition of mitochondrial respiratory function via complex I or IV on dopamine neurons holds a potential significance for the pathogenesis of DA degeneration relevant to the PD pathology.

In summary, we have clearly demonstrated the direct role of mitochondria in DA neuron maturation and an active astrocyte-neuron coordination relationship. The present model provides an approach for the study of abnormal mitochondrial structure, function, and dynamics in the pathogenesis of neurodegenerative diseases and, importantly, an approach for therapeutic discovery in neurodegenerative diseases such as PD.

Experimental Procedures {#sec4}
=======================

hiPSC Culture {#sec4.1}
-------------

Bone marrow 2-3 (BM2-3) from hiPSCs passaged 16--20 times were obtained from Dr. Sunita L. D\'Souza. This BM2-3 iPSC line was derived from the bone marrow of a clinically normal human subject and verified by fluorescence *in situ* hybridization test showing 46, XX. Cytogenetic analysis of cultured human stem cells revealed a normal female karyotype. This analysis did not show any evidence of a clinically significant numerical or structural chromosomal abnormality ([@bib9]). Cells were maintained under feeder-free conditions using Matrigel (BD Biosciences)-coated six-well tissue culture plates in Essential 8 Medium (Life Technologies), supplemented with 10 μM ROCK inhibitor Y27632 (Life Technologies). Cells were routinely passaged as small clumps using a previously described EDTA method ([@bib9]).

Neuron and Astrocyte Co-culture System {#sec4.2}
--------------------------------------

For co-culture experiments, 2.5 × 10^4^ astrocytes per well were first seeded on the 12-well transwell cell culture insert system (pore size 0.4  μm; Falcon, USA) and allowed to grow for 5 days. On day 6, astroglial medium was changed to DA neuronal differentiation medium. After 2 days, the transwell inserts were placed into wells of NPCs during induction, and future experiments were conducted 2 days after the insertion of the astroglial transwells ([Figure 1](#fig1){ref-type="fig"}A).
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